The search for genetic modifiers is an important part of the effort to find treatments.
Overexpression of the RCAN1 gene may be a treatment for Huntington's Disease.
Clear differences were found among the control group, premanifest gene carriers, and those in early stages.
This article describes other possible diagnoses when there are clinical signs of HD but a negative gene test.
